En Es
Categories

Industry News

Esaote and Barco Partner to Improve Ultrasound Diagnostic Capabilities

By Medimaging International staff writers
12 Mar 2018

Image: The Eonis (MDRC-2221) clinical display for image review (Photo courtesy of Barco).Esaote (Genoa, Italy), a manufacturer of medical imaging equipment, and Barco (Kortrijk, Belgium), a healthcare imaging company, have combined their expertise to offer unparalleled ultrasound imaging performance in radiology.

Esaote recently launched MyLab9, its flagship ultrasound system in radiology and shared services, which offers clarity in image quality along with performance and workflow improvement for more efficient and informed healthcare. In addition to new advanced features and hi-tech transducers, the new system configuration includes the latest state-of-the-art 24-inch Eonis display engineered by Barco. The Eonis display presents sharp, bright images and exceptional colors with high contrast for perfect visualization of ultrasound images. The display’s unique front consistency sensor automatically aligns the image quality every time the display is switched on and maintains the luminance for consistent image quality and brightness.

“We are keen to keep investing in delivering the best quality with no compromise: that's why we selected Barco, one of the most accredited partners in radiology to boost performance in the Esaote’s MyLab9 top-end product,” said Luca Bombino, Global Product Marketing Manager.

“Our partnership with Esaote is a clear demonstration of our mission to co-create technology solutions for integrated care. By combining our expertise in diagnostic visualization with the skillset of partners such as Esaote, we are convinced we can enable better health outcomes for more people,” said Mark Bultinck, VP Sales EMEA for Barco Healthcare.



E-mail Print
FaceBook Twitter Google+ Linked in

Barco

Develops medical imaging solutions, including surgical displays, mammography, diagnostic, clinical review displays and mobile point-of-care devices
More info

Additional news

27 Jun 2022
Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries
Given the growing incidence of lifestyle diseases and demand for affordable healthcare, effective surgery using robotic devices can result in a decline in treatment costs and drive the growth of the global robot-assisted surgical devices (RASD) market.
Read More
24 Jun 2022
Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests
Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction of customary closing conditions.
Read More
23 Jun 2022
Hospital Microbiology Testing Market Driven by Increasing Prevalence of Chronic Diseases
Rising medical expenditure as well as the presence of well-established modern healthcare infrastructure in various developed as well as developing regions is fueling the growth of the global hospital microbiology testing market.
Read More
22 Jun 2022
Global Minimally Invasive Surgery (MIS) Market to Surpass USD 325 Billion by 2031
The global MIS market is projected to surpass USD 325 billion by 2031, driven by growing patient awareness of the advantages of MIS over open surgeries, continuous innovation in surgical robots, and constant advancements in other MIS-associated technologies during the 2022-2031 forecast period.
Read More
21 Jun 2022
Medix Biochemica Acquires IVD Raw Materials Producer Bioresource Technology
Medix Biochemica (Espoo, Finland) has acquired 100% of the shares of Bioresource Technology (BRT, Weston, FL, USA) to broaden its base matrix capabilities and further strengthen its local presence in the US market.
Read More
21 Jun 2022
Global Bedside Testing Market to Witness Promising Prospects in Critical Care
Point-of-care or point-of-use diagnostics, also known as bedside testing, has gained increased prominence in analytical testing over the past few years as it provides clinically relevant information without the need for a dedicated laboratory.
Read More
20 Jun 2022
Global Sepsis Diagnostics Market Driven by Rising Hospital-Acquired Illnesses
The global sepsis diagnostics market is expected to grow at a CAGR of 8.3% during the period 2022-2028 to reach almost USD 0.88 billion by 2028, driven by a rise in the number of hospital-acquired illnesses and the rapidly growing molecular diagnostics market, although the high cost of automated diagnostic instruments could hamper market growth.
Read More
14 Jun 2022
BD Partners with Mayo Clinic Platform for Access to World's Largest Collection of Clinical Data
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) has entered into a collaboration with Mayo Clinic Platform (Rochester, MN, USA) to access de-identified patient data from Mayo Clinic Platform_Discover.
Read More
14 Jun 2022
Quidel Partners with Global Lyme Alliance, Leads in Lyme Disease Testing
Quidel Corporation (San Diego, CA, USA) is joining forces with Global Lyme Alliance (Stamford, CT, USA) to heighten public awareness around Lyme disease during Lyme Disease Awareness Month (in May) and beyond.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions